105 related articles for article (PubMed ID: 25351446)
1. V‑set and transmembrane domain‑containing 1 is silenced in human hematopoietic malignancy cell lines with promoter methylation and has inhibitory effects on cell growth.
Li T; Guo X; Wang W; Mo X; Wang P; Han W
Mol Med Rep; 2015 Feb; 11(2):1344-51. PubMed ID: 25351446
[TBL] [Abstract][Full Text] [Related]
2. A functional SNP associated with atopic dermatitis controls cell type-specific methylation of the VSTM1 gene locus.
Kumar D; Puan KJ; Andiappan AK; Lee B; Westerlaken GH; Haase D; Melchiotti R; Li Z; Yusof N; Lum J; Koh G; Foo S; Yeong J; Alves AC; Pekkanen J; Sun LD; Irwanto A; Fairfax BP; Naranbhai V; Common JE; Tang M; Chuang CK; Jarvelin MR; Knight JC; Zhang X; Chew FT; Prabhakar S; Jianjun L; Wang Y; Zolezzi F; Poidinger M; Lane EB; Meyaard L; Rötzschke O
Genome Med; 2017 Feb; 9(1):18. PubMed ID: 28219444
[TBL] [Abstract][Full Text] [Related]
3. [Methylation status of IEX-1 gene promotor CpG island in malignant hematopoietic cell lines].
Li XY; Shen JZ; Shen SF; Fu HY; Zhou HR; Wu DS; Zhang YY; Zheng YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):473-6. PubMed ID: 21518511
[TBL] [Abstract][Full Text] [Related]
4. Role of DNA methylation for expression of novel stem cell marker CDCP1 in hematopoietic cells.
Kimura H; Morii E; Ikeda JI; Ezoe S; Xu JX; Nakamichi N; Tomita Y; Shibayama H; Kanakura Y; Aozasa K
Leukemia; 2006 Sep; 20(9):1551-6. PubMed ID: 16926850
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antitumor activity of triple-regulated oncolytic adenovirus with VSTM1 and daunorubicin in leukemic cells.
Zhou J; Yao QM; Li JL; Chang Y; Li T; Han WL; Wu HP; Li LF; Qian QJ; Ruan GR
Apoptosis; 2016 Oct; 21(10):1179-90. PubMed ID: 27472927
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of monoclonal antibodies against VSTM1.
Li T; Wang W; Chen Y; Han W
Monoclon Antib Immunodiagn Immunother; 2013 Aug; 32(4):283-9. PubMed ID: 23909423
[TBL] [Abstract][Full Text] [Related]
7. [Methylation status of CpG islands in secreted frizzled-related protein gene promoter region of malignant hematopoietic cell lines].
Xu CB; Shen JZ; Shen SF; Fu HY; Wu XM; Wu DS; Zhu YF; Chen L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1487-91. PubMed ID: 20030932
[TBL] [Abstract][Full Text] [Related]
8. HSPB8 is methylated in hematopoietic malignancies and overexpression of HSPB8 exhibits antileukemia effect.
Cui XY; Wang N; Yang BX; Gao WF; Lin YM; Yao XR; Ma XT
Exp Hematol; 2012 Jan; 40(1):14-21. PubMed ID: 21914495
[TBL] [Abstract][Full Text] [Related]
9. [Expression and Promoter CpG Island Methylation Status of miR-34b in Leukemia Cell Lines and Their Clinical Significance].
Guo JX; Zhou YH; Guan RT; Pan JX; Zhang XY; Zhong JF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1235-9. PubMed ID: 26524015
[TBL] [Abstract][Full Text] [Related]
10. [Detection of promoter methylation of p16 gene in hematological malignant cell lines by nested methylation specific polymerase chain reaction].
Zhou HR; Shen JZ; Fu HY; Ye BG; Fan LP; Lin FA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):375-8. PubMed ID: 16638219
[TBL] [Abstract][Full Text] [Related]
11. Expression of VSTM1-v2 Is Increased in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Is Correlated with Disease Activity.
Wang D; Li Y; Liu Y; He Y; Shi G
PLoS One; 2016; 11(1):e0146805. PubMed ID: 26760041
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between DNMT1 and Methylation of SHP-1 Promoter 2 in K562 Cells].
Liu XD; Liu X; Guo XF; Luo JM; Li YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):401-406. PubMed ID: 29665905
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of glucocorticoid receptor gene promoter results in glucocorticoid receptor gene low expression in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
Chen H; Fan J; Shou Q; Zhang L; Ma H; Fan Y
Rheumatol Int; 2015 Aug; 35(8):1335-42. PubMed ID: 25899090
[TBL] [Abstract][Full Text] [Related]
14. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.
Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q
Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418
[TBL] [Abstract][Full Text] [Related]
15. Methylation silencing of the Apaf-1 gene in acute leukemia.
Furukawa Y; Sutheesophon K; Wada T; Nishimura M; Saito Y; Ishii H; Furukawa Y
Mol Cancer Res; 2005 Jun; 3(6):325-34. PubMed ID: 15972851
[TBL] [Abstract][Full Text] [Related]
16. VSTM-v1, a potential myeloid differentiation antigen that is downregulated in bone marrow cells from myeloid leukemia patients.
Xie M; Li T; Li N; Li J; Yao Q; Han W; Ruan G
J Hematol Oncol; 2015 Mar; 8():25. PubMed ID: 25887911
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of the DLC‑1 gene and its inhibitory effect on human colon cancer.
Dai Z; Jin Y
Oncol Rep; 2013 Sep; 30(3):1511-7. PubMed ID: 23783552
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
19. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
[TBL] [Abstract][Full Text] [Related]
20. Promoter CpG methylation of oestrogen receptors in leukaemia.
Yao J; Huang Q; Zhang XB; Fu WL
Biosci Rep; 2009 Aug; 29(4):211-6. PubMed ID: 18808365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
